Fortis Healthcare to Publish Clinical Outcomes for Cardiology to facilitate transperancy
Advertisement
New Delhi: Fortis Healthcare as part of its efforts to strengthen its core value of patient-centric health services became the first private Indian healthcare chain to monitor and publish clinical outcome data for major Cardiology procedures, based on global norms specified by the International Consortium for Health Outcomes Measurement (ICHOM).
These norms enable comparison with best in class results world-wide and allow hospitals to analyze and understand how they stack up globally on factors that determine clinical outcomes. Mr. Bhavdeep Singh, CEO, Fortis Healthcare Limited said, “We are committed to the delivery of value based medicine and in bringing about greater predictability in outcomes. Fortis has always pioneered initiatives that improve the quality of healthcare while making the system transparent and open. I believe this is a significant step in patient empowerment. It further reinforces the measures we are taking to enhance medical care through evidence based protocols that will also provide patients a clear view of the medical options available and the results expected.”
Based on the data, the Fortis Escorts Heart Institute has shown exemplary results and stands out among its peers in a number of areas that top the best available cardiac touchstones globally. FEHI is performing better with zero or negligible cases of post-operative neurological strokes, renal failures, vascular complications, acute vessel occlusions, peri-operative myocardial infarctions and emergency CABG for failed procedures among others.
Mr. Bhavdeep Singh added, “This is a great position to occupy. Patients need to be aware of the results and implications of the procedures they are considering. By publicly declaring salient outcome data that is based on ICHOM norms Fortis has empowered its patients and taken a giant leap amongst all healthcare providers in delivering quality care with safety. "
Dr. Ashok Seth, Chairman, Fortis Escorts Heart Institute said, “This is a huge step towards institutional accountability and doing the best for your patients. The analysis and audit of results in an internationally standardized manner helps us to deliver the best practices in angioplasty and bypass surgery and provides a benchmark to know what we are doing well and what we can do better. It is also the litmus test in our patients about the openness we endeavor to maintain for patients to take informed decisions.” Most importantly our results are audited and open to scrutiny. While this may be a first for India, the future of high quality healthcare delivery over the next year is going to be based on such initiatives, which the patient will need and demand.
Fortis Escorts Heart Institute (FEHI) as part of the ICHOM Coronary Artery Disease Steering Committee became the first Asian hospital to implement the ICHOM Coronary Artery Disease Set for monitoring clinical quality, the incidence of post-operative complications (kidney failure, heart attack, wound infections) in patients undergoing Coronary Artery Bypass Graft (CABG) and Percutaneous Coronary Intervention (PCI).
Dr. Bishnu Panigrahi, Head - Medical Strategy and Operations Group, Fortis Healthcare Ltd. said, “There is a lot of rigour in the process. Following the adoption of the ICHOM methodology, it takes nearly two to three years before stable data becomes available for analysis. Having had a head-start in this space, Fortis is now ready to ramp up and will soon be adding more hospitals and specialties that include the Fortis Memorial Research Institute and Fortis hospitals at Mohali, Mulund and Bangalore for Coronary Artery Disease (CAD). Later this year, Fortis would post outcomes for Kidney Transplant, as well.
Fortis has been a part of the ICHOM Working Group that developed the standard sets for Coronary Artery Disease (CAD). These were rolled out in November’2013 by Prof. Michael Porter at the Harvard Business School, Boston. Since 2014, Fortis is an integral member of the Steering Committee for Coronary Artery Disease (CAD) at ICHOM.
With the availability of relevant hard data Hospitals can continuously measure and improve their clinical outcomes. Equally, the data provides valid and comparable yardsticks with which prospective patients can evaluate their options before making informed choices.
Fortis has taken the lead in this patient friendly endeavor and is the first to display on its website, validated results that are open to public scrutiny. This initiative reinforces organizational accountability and transparency towards its patients and stakeholders. More importantly, it places Fortis squarely among the world’s best hospitals, giving patients, especially international patients, an opportunity to make an informed choice, further boosting the prospects of medical care beyond borders.
FEHI and VitalHealth™, use the proprietary Quest Manager software for reporting clinical outcomes ensuring that the reporting methodology at FEHI conforms to the highest international norms and standards set by ICHOM. It uniquely features Patient-Reported Outcome Measures (PROMs) adding greater objectivity by including the voice of the consumer to the entire initiative.
The International Consortium for Health Outcomes Measurements (ICHOM) is a non-profit organization founded by three esteemed institutions – the Harvard Business School, The Boston Consulting group and Karolinska Institute. The mission of the organization is to standardize sets of outcomes that reflect what matters to most people with individual medical conditions; to support benchmarking which can take place when everyone is measuring the same things on the same platform; complete transparency to patients and clinicians to set common standards to compare with other clinicians. The results then drive adoption and reporting of these measures worldwide. India can benefit from this tremendously to improve its quality of healthcare and also showcase to the world that it adheres to global standards.
Following are the outcomes submitted by Fortis as Comparative analysis with peer set
FEHI_Annexure 1_Comparative analysis_Clinical outcomes data table (Dec'...
These norms enable comparison with best in class results world-wide and allow hospitals to analyze and understand how they stack up globally on factors that determine clinical outcomes. Mr. Bhavdeep Singh, CEO, Fortis Healthcare Limited said, “We are committed to the delivery of value based medicine and in bringing about greater predictability in outcomes. Fortis has always pioneered initiatives that improve the quality of healthcare while making the system transparent and open. I believe this is a significant step in patient empowerment. It further reinforces the measures we are taking to enhance medical care through evidence based protocols that will also provide patients a clear view of the medical options available and the results expected.”
Based on the data, the Fortis Escorts Heart Institute has shown exemplary results and stands out among its peers in a number of areas that top the best available cardiac touchstones globally. FEHI is performing better with zero or negligible cases of post-operative neurological strokes, renal failures, vascular complications, acute vessel occlusions, peri-operative myocardial infarctions and emergency CABG for failed procedures among others.
Mr. Bhavdeep Singh added, “This is a great position to occupy. Patients need to be aware of the results and implications of the procedures they are considering. By publicly declaring salient outcome data that is based on ICHOM norms Fortis has empowered its patients and taken a giant leap amongst all healthcare providers in delivering quality care with safety. "
Dr. Ashok Seth, Chairman, Fortis Escorts Heart Institute said, “This is a huge step towards institutional accountability and doing the best for your patients. The analysis and audit of results in an internationally standardized manner helps us to deliver the best practices in angioplasty and bypass surgery and provides a benchmark to know what we are doing well and what we can do better. It is also the litmus test in our patients about the openness we endeavor to maintain for patients to take informed decisions.” Most importantly our results are audited and open to scrutiny. While this may be a first for India, the future of high quality healthcare delivery over the next year is going to be based on such initiatives, which the patient will need and demand.
Fortis Escorts Heart Institute (FEHI) as part of the ICHOM Coronary Artery Disease Steering Committee became the first Asian hospital to implement the ICHOM Coronary Artery Disease Set for monitoring clinical quality, the incidence of post-operative complications (kidney failure, heart attack, wound infections) in patients undergoing Coronary Artery Bypass Graft (CABG) and Percutaneous Coronary Intervention (PCI).
Dr. Bishnu Panigrahi, Head - Medical Strategy and Operations Group, Fortis Healthcare Ltd. said, “There is a lot of rigour in the process. Following the adoption of the ICHOM methodology, it takes nearly two to three years before stable data becomes available for analysis. Having had a head-start in this space, Fortis is now ready to ramp up and will soon be adding more hospitals and specialties that include the Fortis Memorial Research Institute and Fortis hospitals at Mohali, Mulund and Bangalore for Coronary Artery Disease (CAD). Later this year, Fortis would post outcomes for Kidney Transplant, as well.
Fortis has been a part of the ICHOM Working Group that developed the standard sets for Coronary Artery Disease (CAD). These were rolled out in November’2013 by Prof. Michael Porter at the Harvard Business School, Boston. Since 2014, Fortis is an integral member of the Steering Committee for Coronary Artery Disease (CAD) at ICHOM.
With the availability of relevant hard data Hospitals can continuously measure and improve their clinical outcomes. Equally, the data provides valid and comparable yardsticks with which prospective patients can evaluate their options before making informed choices.
Fortis has taken the lead in this patient friendly endeavor and is the first to display on its website, validated results that are open to public scrutiny. This initiative reinforces organizational accountability and transparency towards its patients and stakeholders. More importantly, it places Fortis squarely among the world’s best hospitals, giving patients, especially international patients, an opportunity to make an informed choice, further boosting the prospects of medical care beyond borders.
FEHI and VitalHealth™, use the proprietary Quest Manager software for reporting clinical outcomes ensuring that the reporting methodology at FEHI conforms to the highest international norms and standards set by ICHOM. It uniquely features Patient-Reported Outcome Measures (PROMs) adding greater objectivity by including the voice of the consumer to the entire initiative.
The International Consortium for Health Outcomes Measurements (ICHOM) is a non-profit organization founded by three esteemed institutions – the Harvard Business School, The Boston Consulting group and Karolinska Institute. The mission of the organization is to standardize sets of outcomes that reflect what matters to most people with individual medical conditions; to support benchmarking which can take place when everyone is measuring the same things on the same platform; complete transparency to patients and clinicians to set common standards to compare with other clinicians. The results then drive adoption and reporting of these measures worldwide. India can benefit from this tremendously to improve its quality of healthcare and also showcase to the world that it adheres to global standards.
Following are the outcomes submitted by Fortis as Comparative analysis with peer set
FEHI_Annexure 1_Comparative analysis_Clinical outcomes data table (Dec'...
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.